Cohanzick Management’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,373,225
Closed -$13.6M 448
2021
Q3
$13.6M Sell
1,373,225
-32,123
-2% -$319K 3.29% 4
2021
Q2
$13.9M Buy
+1,405,348
New +$13.9M 4.4% 3